Yan'an University Xianyang Hospital

Xianyang, Shaanxi 716000

3 studies enrolling now · 5 studies all time

What they study most

Acute Non-cardioembolic Ischemic Stroke, Atrial Fibrillation, High-risk Transient Ischemic Attack, Obesity or Overweight, Pediatric Migraine, Prevention of Ischemic Stroke, Prevention of Stroke or Systemic Embolism, Type 2 Diabetes Mellitus

Studies at this site

• Randomized Study in Children and Adolescents With Migraine: Acute Treatment — Recruiting now
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes — Recruiting now
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Recruiting now
• A Study to Test Asundexian for Preventing a Stroke Caused by a Clot in Participants After an Acute Ischemic Stroke or After a High-risk Transient Ischemic Attack, a So-called Mini Stroke — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early